Abstract External Quality Assessment (EQA) schemes are national or transnational programmes designed to control the analytical performance of clinical laboratories and to maintain inter-laboratory variability within acceptable limits. In such EQA programmes, participants are usually grouped by the type of assay technique/equipment they use. The coefficient of variation (CV) is a simple tool for comparing the inter-laboratory reproducibility of such techniques: the lower the CV, the better the analytical performance.
Introduction
To control the analytical performance of clinical laboratories, External Quality Assessment (EQA) programmes have been implemented worldwide for many years. These programmes, traditionally organized by healthcare authorities or external agencies, have greatly improved the inter-laboratory compatibility of tests results and hence clinical decision making.
It is known that assay techniques and equipments used by the participants are a source of inter-laboratory imprecision and bias. Not only do calibrators, reagents or kits utilized affect the results, but also other parameters such as the temperature can explain additional variability. Despite international harmonization guidelines and recommendations, the fact that laboratories continue to use different assay methods is an important factor to take into account in EQA programmes. Therefore, EQA organizers generally group participants according to the analytical principle or equipment they use for doing the tests. The statistical analysis of the data is then carried out for each -analytical‖ group separately. A -robust‖ mean (M) and standard deviation (SD) are calculated, so that for each individual laboratory
can be derived. Laboratories exceeding a certain critical distance d* from their peers in the group will be considered as -poor-performers‖. As summary statistics, EQA organizers also compute for each group the coefficient of variation (CV), in order to compare the analytical performance of the various techniques.
Serum protein electrophoresis was only recently implemented in EQA schemes, in particular for controlling the detection and characterization of monoclonal immunoglobulins.
Electrophoresis separates serum proteins into five fractions, specifically albumin, α 1 , α 2 , β and γ globulins, reported as absolute values (g/L) or as relative proportions (expressed in %) of total serum protein. When expressed in percent, the five electrophoretic fractions sum up to 100% [1] . As for other analytes, the electrophoretic technique is an important factor likely to influence the final results. These techniques essentially depend on the media (agarose gel, cellulose acetate electrophoresis [1] ) or on the analytical principle (e.g., the recently developed capillary zone electrophoresis [2] [3] [4] ). In a recent paper [5] , we proposed a robust multivariate method to analyse EQA electrophoresis data. This method supersedes the traditional approach of viewing each fraction separately (as for ordinary tests) by providing a global assessment of each electrophoretic profile.
The present work was specifically oriented towards the generalization of the coefficient of variation as a way to compare the inter-laboratory variability of electrophoretic techniques, as done for single laboratory tests. This is achieved in two steps. First, because of the compositional nature of electrophoretic data (their fractions sum up to 100%), a one-to-one transformation is applied to the fractions to break the linear constraint and keep only four variables for subsequent calculations. Second, a robust mean and covariance matrix is calculated for the 4-dimensional vector of transformed data. Finally, a multivariate -robust‖ CV is computed by using a Mahalanobis distance between the mean vector and the origin.
The comprehensive development is illustrated on serum protein electrophoresis material from the French and Belgian EQA programmes.
Study material
Serum protein electrophoresis results were obtained from laboratories participating in the 2004 French and Belgian EQA programmes for the same control sample (04G9). It was a liquid specimen of human origin, which contained a monoclonal IgM-lambda paraprotein concentrated to 5 g/L, emphasizing a narrow peak in the zone of γ-globulin of the electrophoretic profile. There were 2376 participants (out of 2965 registered laboratories in the field of immuno-pathology) who actually returned their electrophoresis results to the EQA agencies. Among these, 93 (4%) electrophoretic profiles for which the sum of the five fractions was not equal to 100% up to rounding errors (say ± 0.2%) were discarded from the analysis and considered as not satisfactory. For all other electrophoretic profiles, prior to the statistical analysis, the five fractions were multiplied by a common factor fractions) observed of sum ( % 100   to sum up to exactly 100%.
A total of 28 different assay techniques were reported by the participants according to media/analytical principle, stain colour and reagent. Only techniques including at least 20  n participants were considered in this work. There were 13 such techniques corresponding to a total of 2196 participants (see Table 1 ). The 13 assay techniques were classified in four major categories: agarose gel-acid blue (n = 227, 10%), agarose gel-amido black (n = 1600, 73%), cellulose acetate membrane-Ponceau S (n = 207, 9%) and capillary zone electrophoresis (n = 162, 7%). As seen in Table 1 
Univariate coefficients of variation
The coefficient of variation (CV) is a widely used measure in EQA, and in laboratory medicine in general, to assess and compare the reproducibility of techniques and equipments.
By definition,
where M represents the mean concentration of the analyte in the control sample and SD the inter-laboratory variability. Since the coefficient of variation is usually expressed in percent,
Eq.
(1) will be multiplied by 100%. Robust estimates of M and SD are generally required, because EQA datasets often entail outliers or blunders which seriously bias their estimation.
Traditionally, 50 P M  , the sample median, and   25 75
, where P 25 and P 75 are the first and third quartiles of the sample of results, respectively [6] . As an example, Table 2 displays the robust estimates of M and SD for each electrophoretic fraction as obtained from the 903 participants using the -Sebia Hydragel ® (Hydratest) (HR) Protein Hydrasys‖ technique. The corresponding values for all assay techniques are given in Appendix 1. Once reliable estimates of M and SD are obtained, they can be plugged into Eq. (1) yielding a robust estimate of the CV (see Table 2 ). Univariate CVs for each electrophoretic fraction and each electrophoretic technique are displayed in While it is convenient and straightforward to calculate the CVs of the five fractions by technique, it would be more appropriate to provide an overall assessment of the various electrophoretic techniques and to rank them in some way. This can be achieved by computing a multivariate CV for each technique, which accounts for the linear constraint of the 5 fractions and for the correlations between them. In addition, the multivariate CV should not be affected by outlying electrophoretic profiles in the dataset. S is invertible, which is not the case for electrophoretic profiles. In a previous paper of our group [5] , we avoided this problem by working with a 4-dimensional electrophoretic profile, merely by discarding one of the fractions. Unfortunately, if we use this approach, Eq. (2) yields a different CV M value for each fraction deleted. We strived to circumvent this problem by proceeding with a 2-step procedure as described hereafter.
Step 1. Electrophoresis data transform. The fact that the five electrophoretic fractions sum up to 100% makes the multivariate statistical analysis unreliable [11] . The linear constraint imposed on the five fractions locates these fractions on a so-called simplex space, which is a subset of the real space. It follows that the covariance matrix, based on the five fractions, is singular and not invertible. Therefore, there is a need to transform the constrained data into an unconstrained real space. Among the family of log-ratio transformations, three are worth mentioning, the additive log-ratio (ALR) [11] , the centered log-ratio (CLR) [12] and the isometric log-ratio (ILR) transformation [13] . In the present work, we decided to opt for the ILR transform which overcomes the problems of asymmetry of the ALR and of collinearity of the CLR transforms [13] . Let 
It should be noted that any zero electrophoretic fractions in Eq. (3) Step 2. Robust multivariate estimation. As already mentioned, EQA organizers are traditionally facing the problem of outlying results. This also holds for electrophoretic profiles. The classical mean and covariance matrix (even after the transform above) can be markedly affected even by a single -poor-performer‖, emphasizing the need for robust estimates [5] . There are plenty of robust methods available, but one of the most attractive rests upon the minimum covariance determinant (MCD) concept developed by Rousseeuw [14] . In addition, the MCD method can also be applied for compositional data [15] . This approach shows many advantages: high robustness, fast algorithm (FAST-MCD) and affine equivariant estimators [16] . According to the FAST-MCD algorithm, the MCD approach consists in finding h observations (in this study, h = 0.75n) whose classical covariance matrix provides the lowest determinant. The initial location estimate is then the average of these h points and the initial scatter estimate is their covariance matrix. Afterwards, the initial covariance matrix is multiplied by a consistency factor to obtain multivariate normality and a correction factor to be unbiased for small sample sizes [17] . The final covariance matrix y S is obtained by using a weighting step to achieve better efficiency (see -covMcd‖ function in the -robustbase‖ package of R 2.9.2 [18] ). From the matrix y S , it is convenient to derive the correlation matrix y R which is easier to interpret for the user. As a reminder, the correlation between two variables is equal to the covariance between the two variables divided by the product of their standard deviations.
The MCD estimates will differ according to which fraction is used as the reference basis for the ILR-transformation. However, in our case, this does not matter since the final robust estimate of the multivariate CV will always be the same. We applied the MCD method to each electrophoretic technique to obtain robust estimates of the mean ( y ), covariance matrix ( y S ) and correlation matrix ( y R ). As an illustration, Table 4 After getting the MCD mean y and covariance matrix y S from the ILR-transformed results, the value of the multivariate coefficient of variation can be directly calculated for each technique by the following equation (multiplied by 100%)
An estimation of the standard error (SE) of CV M can be obtained by the bootstrap method [19] . However, this computer intensive method is sensitive to the presence of outlying observations. Therefore, outliers were first removed from the dataset based on the approach recommended in [17] and then the bootstrap was applied to each cleaned dataset. The robust multivariate CV was calculated for each electrophoretic technique using Eq. (4) and expressed in percent. Results are displayed in Table 5 The values of CV M (± SE) were also calculated for the four major electrophoretic categories: agarose gel-acid blue (5.9 ± 0.29%), agarose gel-amido black (4.4 ± 0.08%), cellulose acetate membrane-Ponceau S (7.8 ± 0.39%) and capillary zone electrophoresis (3.7 ± 0.18%). Note that the fully -automated‖ capillary zone electrophoretic technique showed the lowest CV.
Discussion
The systematic implementation of EQA surveys to control the analytical performance of clinical laboratories generates vast amount of data. The statistical analysis of EQA data pursues several goals: first to provide reliable estimates of the mean (i.e., the concentration of the control specimen) and of the standard deviation (i.e., the inter-laboratory variability);
next, to unveil laboratories with outlying results (so called, poor-performers) as compared to the other participants, so that corrective actions or even sanctions can be taken; finally, to highlight unsatisfactory analytical techniques, which can be progressively removed from the market and replaced by better ones. In the latter case, the CV is a useful and widely accepted indicator for comparing the performance of assay techniques or instruments.
Traditionally, EQA schemes have been mainly focussing on single tests (e.g., substrates, enzymes, hormones) so that statistical methods (including robust methods) are pretty straightforward to apply and are easily understood by the laboratory medicine community.
When it comes to laboratory profiles, like serum protein electrophoresis, things get somewhat more complicated as profile components (electrophoretic fractions) have to be analysed and interpreted globally and not separately.
In a previous paper of our group [5] , we proposed a novel statistical method to analyse EQA electrophoresis data and to get reliable estimates of the mean and dispersion suffers from a few drawbacks. It is highly sensitive to outliers, so that a robust approach is required to obtain a reliable estimate. It can not be calculated if the tests of the profile are linearly related (as it is the case for protein electrophoresis) because the covariance matrix can not be inverted. By deleting one fraction of the electrophoretic profile, however, the covariance matrix is no longer singular. Unfortunately, the CV M will be different for each fraction removed. To circumvent these shortcomings, we applied a two-step procedure: (1) the ILR-transform of the 5 electrophoretic fractions to derive a 4-dimensional profile, and (2) to use the MCD method for estimating the mean vector and covariance matrix of the new 4-dimensional vector. The multivariate CV can then be derived by utilizing the latter estimates.
The method has proven to work quite well and experience has shown that a sample of at least 20 laboratories is needed to get reliable robust estimates. For groups with less than 20 participants, the MCD method is shakier and we recommend simply computing classical estimates of the mean and covariance matrix. Results however have to be considered with utmost care.
The multivariate coefficient of variation was illustrated on a database from the joint French and Belgian EQA electrophoretic programmes, thus allowing having a sufficient number of laboratories within each electrophoretic technique group. The novel approach enabled to rank these techniques by increasing inter-laboratory variability, which could hardly have been done on the basis of the univariate CVs of the 5 fractions. Multivariate CVs ranged between 2.45% to 7.82% and given the large sample sizes in some of the groups, significant CV differences could be highlighted between several techniques.
We believe that the method proposed in this work is quite feasible since the ILR-transform is easy to apply and the R programme to calculate the robust MCD estimates is a freeware that can be downloaded. It was remarked that the value of the multivariate CV does not depend on which fraction of the electrophoretic profile was chosen as the reference (here we selected γ-globulin but any other fraction could have been used). Our method is applicable whenever a multivariate profile is available. In case data are not compositional, the first step can be skipped and the user can straightforwardly proceed with the robust estimation of the mean and covariance matrix.
